Chesham-based startup, Flomark, has secured a £150,000 investment from British Design Fund (BDF) and £150,000 from Imperial College Enterprise Fund (ICEF) as part of a broader funding round, as it looks to accelerate the development of its pioneering solutions aimed at making IV drips safer for patients.
Flomark is on a mission to transform the way fluid balance is monitored in healthcare settings. The company’s innovative technology addresses critical gaps in patient care by providing accurate data on infusion flow rates and urine output, which are currently difficult to measure reliably.
While previously nurses would need to stand and count the drops coming out of an IV drip, Flomark’s patented technology makes it possible to see at a glance how fast fluid is flowing through it and entering a patient, saving nurses time and supporting the more accurate delivery of fluids.
The Flomark is a sterile, single-use flow meter that integrates with standard gravity IV sets and provides a simple visual indicator of flow rate. The device incorporates a float – a little red ball – and a visual scale showing millilitres per hour.
A spin-out from the Royal College of Art, the company’s founders, Jonathan West, Gianpaolo Fusari, and James Kinross, combine expertise in engineering, design, and healthcare.
Flomark’s technology is designed to help patients by reducing harm caused by Acute Kidney Injury and Fluid Overload, simplifying nurses’ workflows, providing doctors with reliable data, and reducing costs for hospitals.
The investment from BDF and ICEF will support Flomark’s plans to launch its first product later this year and bring its pipeline of devices to market in the coming years. The funding will also enable further research and development to enhance its solutions.
